Beranda › Sindrom Mielodisplastik › Idaho › Boise
Uji klinis Sindrom Mielodisplastik di Boise, ID
4 studi untuk Sindrom Mielodisplastik mencari peserta di lokasi sekitar Boise (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Menerima pesertaFase 2
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Luke's Cancer Institute - Boise, Boise
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- Saint Luke's Cancer Institute - Boise, Boise
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Menerima pesertaFase 1/2
- Saint Luke's Cancer Institute - Boise, Boise
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Boise
Uji klinis Sindrom Mielodisplastik di kota lain
- Houston, TX43 studi
- Baldwin Park, CA26 studi
- New York City, NY21 studi
- Seattle, WA21 studi
- Washington, DC20 studi
- Tampa, FL19 studi
- Boston, MA19 studi
- Miami, FL17 studi
- Durham, NC14 studi
- Columbus, OH14 studi
- St. Louis, MO13 studi
- Atlanta, GA13 studi
Studi lain di Boise
- Kanker Paru Non-Sel Kecil14 studi
- Kanker Paru11 studi
- Leukemia Mieloid Akut8 studi
- Kanker Prostat8 studi
- Kanker Kolon7 studi
- Kanker Kolorektal6 studi
- Sindrom Distres Respirasi6 studi
- Kanker Payudara6 studi
- Melanoma6 studi
- Limfoma Burkitt5 studi
- Kanker Pankreas4 studi
- Neoplasma Mieloproliferatif4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.